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Latest data on deaths from obstetric 
haemorrhage in South Africa
There is ongoing concern at the slow rate of reduction of mortality 
from obstetric haemorrhage (OH) in South Africa (SA), despite 
several educational interventions. OH was the third most common 
cause of maternal death for the triennium 2014 - 2016, accounting for 
624 deaths or 16.9% of the total,[1] compared with 684 (15.8%) deaths 
in 2011 - 2013. The OH-related maternal mortality ratio (MMR) 
was 22.7 deaths per 100 000 live births, i.e. ˂24.3 in 2011 - 2013, but 
>18.8 in 2005 - 2007. There was considerable provincial variation in 
the MMR; haemorrhage was highest in Limpopo Province (33.5), 
Mpumalanga Province (32.7) and North West Province (28.9) and 
lowest in Western Cape Province (7.4).                   
The major causes of death from haemorrhage were bleeding 
associated with caesarean delivery (CD) (34.9%), uterine rupture 
(15.1%), abruptio placentae (12.9%), uterine atony (9.5%) and 
retained placenta (6.9%). Of concern was the persisting high number 
of deaths due to bleeding after CD, which was described in an 
interim publication.[2] The majority of OH deaths (93.9%) occurred 
at public hospitals, 32.4% at district hospitals, 30.4% at regional 
hospitals and 27.3% at tertiary hospitals. This might not reflect the 
level of care where delivery occurred, as many women were referred 
from district level, with bleeding after delivery or CD, to a regional 
or tertiary facility.[2] Assessors judged the majority (87.8%) of OH 
deaths to be possibly or probably avoidable. Review of the folders 
of OH deaths identified ‘red flags’, e.g. common omissions (poor 
problem recognition), commissions (incorrect treatment) and areas 
of substandard care (inadequate monitoring and/or management). 
These lessons learnt have led to the following key practice points for 
managing OH.
Referral to an appropriate level of care 
for delivery                       
Although it is not possible to predict with certainty which women 
will have postpartum haemorrhage (PPH), there are some known 
antenatal and intrapartum predictive factors.[3] Antenatally, these 
include anaemia, multi-fibroid uterus, previous PPH, previous CD, 
placenta praevia, pre-eclampsia, parity ≥5, multiple pregnancies and 
antepartum haemorrhage. Intrapartum factors include prolonged first 
stage of labour, prolonged second stage of labour, chorioamnionitis 
and abruptio placentae. Such women need to be identified for 
delivery at district or regional hospital level, where skilled doctors 
of the appropriate level and blood products are available. When 
an identified woman lives far from the referral hospital, maternity 
waiting areas can enable her to be closer to the appropriate facility 
when her labour commences.
Prevention of postpartum 
haemorrhage
Active management of the third stage of labour with 10 IU intra-
muscular oxytocin reduces the risk of PPH by 60% and should be 
employed routinely for birth at a facility.[4] This can be followed by 
a 20 IU oxytocin infusion or intramuscular oxytocin/ergometrine 
combination preparation for women at increased risk of PPH. High 
blood pressure (BP) and cardiac disease are contraindications to 
ergometrine administration. Similarly, at CD, prophylaxis with 
oxy tocin should be employed. Because of concern regarding hypo-
tension from rapid intravenous oxytocin boluses, especially in 
combination with spinal anaesthesia, smaller slower boluses should 
be given, supplemented with an infusion.[5] Alternatively, oxytocin 
or the oxytocin/ergometrine combination can be administered 
intramuscularly if there are no contraindications.[6] Other inter ventions 
that reduce the likelihood of PPH include vigilant intrapartum moni-
toring to prevent obstructed labour by timely CD, availability of skill 
for operative vaginal delivery to avoid unnecessary CD in the second 
stage of labour, and good surgical technique for CD. 
Being prepared
Good ward-level management by a senior nurse, with support 
of the facility procurement department, is important to ensure 
continuous availability of essential medications, fluids, infusion sets 
and equipment for balloon tamponade. If all of the above are in a 
‘PPH box’, time will not be wasted searching for items during an 
emergency, and the completeness of the items can be more easily 
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checked on a daily basis. Furthermore, it 
is very important that there is an adequate 
supply of blood products. This could be an 
on-site blood bank (as at tertiary hospitals 
and some regional hospitals). However, 
such a resource is not available for district 
hospitals and the majority of regional 
hospitals, where there must be efficient 
oversight to ensure a functioning fridge 
with adequate supplies of emergency blood, 
which is replaced in an ongoing manner 
after use. Also, fresh dried plasma (FDP) 
should be procured as a pharmacy item 
and kept in the labour ward and/or theatre. 
Regular on-site emergency drills (emergency 
obstetric scenario training), where the team 
practise how to take care of a severe PPH, 
are essential to ensure that they know what 
to do and how to do it.[7]
Early detection of 
haemorrhage (before 
coagulopathy)
After massive blood loss (>2 L), a coagulo-
pathy develops and all attempts to stop the 
bleeding become more complex and hazard-
ous. Therefore, early recognition of PPH with 
prompt treatment can prevent progression to 
severe shock and coagulopathy. The mandatory 
2 hours of monitoring after vaginal delivery with 
15-minute observations of vital signs should 
be adhered to. A similar period of monitoring 
after CD in a designated recovery area should 
also be a standard routine. The African Surgical 
Outcomes Study (ASOS)[8] identified CD as the 
most common surgical operation performed in 
Africa and identified the immediate postopera-
tive period as a critical time for early detection 
of surgical complications. Colour-coded early-
warning monitoring charts aid in the identifica-
tion of problems.[9]
During this monitoring period – beware the 
‘slow trickle’, which may add up to severe blood 
loss and lead to sudden decompensation; and 
beware the ‘tachycardia’, which is usually the 
first sign of above-average blood loss and 
should not be ignored.
Not all OH is visible: beware the concealed 
bleeding from abruptio placentae, ruptured 
uterus, paravaginal haematoma, or post-CD 
intra-abdominal bleeding. A patient with 
a retained placenta does not remain stable, 
and severe PPH is likely to ensue if the 
placenta is not removed at the site where she 
delivered. Therefore, midwives at primary 
level need to be trained to perform manual 
removal of the placenta. Early resuscitation 
with crystalloid fluids is essential to replace 
blood volume, but after 3 L of crystalloid alone, 
there is an increased risk of coagulopathy. 
Therefore, blood usually needs to be given 
before this stage during ongoing bleeding.[10] 
A shock index (pulse/systolic BP) of >0.9 
is an early sign of hypovolaemia. It is 
also an indication to call a doctor and for 
intervention.[11] Early involvement of the 
doctor as part of the team to manage PPH 
is essential. Importantly, doctors should not 
wait for the BP to drop before attending to 
the patient, because by this time she is likely 
to have bled at least 2 L.
Emergency management 
of severe obstetric 
haemorrhage 
After 1.5 - 2 L of blood loss, there will be symp-
toms and signs of shock (dizziness, confusion, 
low BP, tachycardia, pallor and oliguria). Severe 
PPH, if untreated, can lead to death within 2 - 
3 hours (NB: referral is not treatment).
Beware if the pulse is twice as high as 
the systolic BP reading. A shock index of 
>1.7 requires an urgent response and should 
initiate calling the OH team, where such 
teams exist, or the most senior medical and 
nursing staff on site, in the absence of such 
teams, as in smaller hospitals.[11] This is a 
dire emergency; the patient must not be left 
until bleeding stops and signs improve, and 
help must be summoned immediately. In 
regional and tertiary hospitals, haematologists, 
the blood bank and in some situations, 
interventional radiologists need to be 
alerted. In other regional and all district 
hospitals the most senior doctor, including a 
doctor experienced in anaesthesia, needs to 
be summoned. Aggressive resuscitation and 




• After vaginal delivery
• 10 U oxytocin IM after delivery
• Controlled cord traction
• At risk of PPH
• Consider oxytocin infusion or 
  ergometrine in addition to above
Undelivered
• Repeat cord traction
• Manual removal of placenta
Soft
• Massage uterus and expel clots
• Continue oxytocin infusion
• Ergometrine* 0.5 mg or
  oxytocin/ergometrine 1 amp IM
  and
• Tranexamic acid† 1 g IV
  (can repeat x 1)
• Misoprostol 400 - 600 μg 
   sublingually or orally
• Balloon tamponade
If ongoing bleeding
• Examine in theatre‡
• Explore for retained products




• Uterine brace sutures
• Uterine artery ligation
• Hysterectomy
Firm
• Suture lacerations of




Resuscitation and immediate treatment
• Rub up the uterus/bimanual compression
• Call for assistance
• Insert 2 large IV cannulas
• Infusion of oxytocin 20 U in 1 L Ringer’s lactate
• Maintain BP with clear uids/blood
• Urinary catheter
• Monitor BP/pulse/urine output
Diagnosis
• Blood loss after birth >500 mL
   or
   appears excessive
Not felt
• Check vaginally for
   inverted uterus
• Replace immediately
• Hydrostatic reduction
• Saline infusion into
  vagina
• Hold vulvae around
  tube or use rubber
  vacuum cup in
  vagina for seal
Incomplete
• Evacuation of uterus
• Digital exploration
• Ovum forceps and largest
  curette
Fig. 1. Postpartum haemorrhage after vaginal delivery. (IM = intramuscular; PPH = postpartum 
haemorrhage; IV = intravenous; BP = blood pressure; amp = ampoule.) (*Avoid if increased BP or 
cardiac condition; †Avoid if venous thromboembolism or artificial heart valves; ‡In facilities with 
no theatre, patient will need emergency referral. To optimise condition, consider: balloon catheter 
tamponade; non-pneumatic anti-shock garment, if available.)
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of the bleeding and stop it, must take place 
concurrently, with another person available 
to document findings and treatment and 
make phone calls.
Resuscitation
Use of blood products, such as red cells, 
fresh frozen plasma (FFP), cryoprecipitate 
and platelets, can be goal-directed in well- 
resourced settings, where immediate 
haematology results can guide blood-product 
component therapy replacement.[10] There 
is a move to the earlier administration of 
fibrinogen-rich products.[10-12] Unfortunately, 
in SA, this is not the norm and blood-
product replacement is ‘formula driven’.[13,14] 
The national PPH guideline recommends the 
following: after 2 L of crystalloid, +/- colloid, 
transfuse 2 U of red cells, followed by 1 U of 
FDP or FFP for every further red cell unit 
given. The use of point-of-care tests, such as 
HemoCue (HemoCue, SA) for haemoglobin 
estimation, can assist in decision-making, 
and in the future, thrombo-elastography 
may have value in poor-resource settings, 
although this is still being researched.[12]
Identify cause/s of bleeding
This step is often overlooked, with PPH being 
seen as a diagnosis in itself requiring only 
medical therapy. While uterine atony is the 
most common cause of PPH after vaginal 
delivery, and it is recommended to always 
commence an oxytocin infusion as the first 
line of treatment, it is also important to 
consider other causes. Overlooking major 
vaginal trauma or even ruptured uterus can 
cause delays in definitive treatment and result 
in death. Also, there may be more than one 
cause of PPH, e.g. retained products or a 
cervical tear might co-exist with uterine atony.
Medical treatment of postpartum 
haemorrhage
This includes uterotonic drugs to contract 
the uterus, which are given sequentially; 
followed 10 - 15 minutes later by an oxytocin 
infusion if there is no response after 
oxytocin/ergometrine or ergometrine (if no 
contraindications), as well as tranexamic 
acid. The last, a fibrinolytic inhibitor, was 
not previously in the SA PPH protocol, 
but the WOMAN trial[15] indicated that 
it reduces PPH mortality compared with 
placebo when administered in addition 
to standard therapy. A dedicated World 
Health Organization guideline[16] specifies 
the importance of using it early in the 
PPH algorithmic approach, as its effect is 
reduced if given after 3 hours of onset of 
PPH. It is now included in the new SA 
PPH protocol. Contraindications include 
artificial heart valves and current or previous 
thromboembolic disease. Prostaglandins 
have also been used for PPH. Prostaglandin 
F2-alpha is no longer available globally. 
There is a place for sublingual misoprostol 
to promote uterine contraction, but avoid 
high doses, which lead to morbidity.[17] It 
could be a second-line agent in patients with 
contraindications to oxytocin/ergometrine 
or when there is cold-chain failure for 
storing the other uterotonic drugs that 
require refrigeration. 
Non-medical interventions for 
postpartum haemorrhage in the 
labour ward
These interventions, including manual removal 
of the placenta, can be done in community 
health clinics, midwife obstetric units (MOUs) 
and district hospitals. They include bimanual 
compression, aortic compression, suture of 
perineal tears and balloon tamponade. The 
last can involve purpose-made devices, such as 
the Ellavi balloon (Sinapi, SA), Rusch catheter 
(Teleflex Medical, USA) or Bakri balloon (Cook 
Medical, USA), or ‘home-made’ devices that 
use condoms or surgical gloves to make the 
balloon.[18] Urgent referral is essential in facilities 
that do not have on-site doctors or theatre facilities, 
such as clinics/MOUs, and in patients in whom 
the initial treatment measures described above 
do not succeed. Advice must be obtained from 
the referral hospital before transfer. 
Early recourse to theatre
If bleeding persists despite all medical and non-
medical labour ward interventions, another 
cause needs to be sought. Early recourse to 
theatre is needed in this situation, and also 
when immediate post-delivery findings suggest 
Bleeding at caesarean section
Management
Prevention – intraoperative
• 2.5 IU oxytocin IV for
  30 s after delivery of baby, 
  + 7.5 IU in drip
• Repeat 2.5 IU IV if poor
  uterine contraction
• Delivery of placenta by
  cord traction
• Good surgical technique
NB: alternatives for intraoperative
prevention
• Oxytocin 10 IU IM or 
    I amp oxytocin/ergometrine IM
Prevention – postoperative
• Oxytocin infusion (20 IU/L for 8 h)
   and/or 
   oxytocin/ergometrine IM 







• Blood loss in suction bottles
   >500 mL
• ↓BP and ↑HR as detected by
   anaesthetist
Resus/early Rx (anaesthetist)
• Second IV line
• Maintain BP with uids and blood
• 20 IU oxytocin in 1 L infusion
• Tranexamic acid 1 g IV





• Continue oxytocin infusion
• Ergometrine 0.2 mg IV (not
  hypertensive/cardiac);
  repeat x 1
   (or 0.5 mg ergometrine IM or 
  1 amp oxytocin/ergometrine IM)
• Repeat tranexamic acid x 1
• Misoprostol 400 - 600 μg 
   sublingually
• Uterine compression suture





• Uterine artery ligation
• Inferior tears
• Secure apex and suture  
    (check ureters are
     lateral to tear)
• Rupture
• Repair or subtotal








Fig. 2. Excessive bleeding at caesarean delivery. (IV = intravenous; IM = intramuscular; amp = ampoule; 
PPH = postpartum haemorrhage; BP = blood pressure; HR = heart rate; Resus = resuscitation; 
Rx = treatment.) (*Proceed immediately to subtotal abdominal hysterectomy (STAH) if: uterine rupture 
(irreparable); placenta percreta; †If lack of skill for STAH, apply uterine tourniquet and refer; ‡Non-
pneumatic anti-shock garment, if available.) 
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retained placenta, retained products or trauma 
not amenable to repair in the labour ward, 
e.g. deep vaginal tears or suspected cervical/
uterine trauma. Consent for examination 
under anaesthesia and additional procedures 
that may be required, such as laparotomy or 
hysterectomy, needs to be obtained at this stage. 
Examination under anaesthesia can be done 
at district hospital level and is preferable to 
transferring unstable patients without some 
form of definitive or temporising treatment. 
Early recourse to theatre for patients with 
bleeding after CD is very important and can 
also be done at a district hospital after informing 
the referral hospital about the patient.
Surgical interventions for 
postpartum haemorrhage
Removal of placental products, suture of 
vaginal/cervical tears, balloon tamponade, 
repair of uterine tears at CD, and lapa-
rotomy for uterine compression sutures can 
be performed at all levels of hospital. Details 
for these procedures are not described in 
this article, but can be referred to in the 
Monograph on the Management of Post -
partum Haemorrhage[13] and the caesa rean 
section monograph,[19] and are taught in the 
essential steps in managing obstetric emer-
gencies (ESMOE) modules.[7] Hysterectomy is a 
life-saving procedure that must be done when 
the abovementioned conservative surgical 
measures fail, or imme diately in cases of 
extensive uterine rupture or placenta increta/
percreta. How ever, it is a specialised opera-
tion requiring greater gynaecological skill 
than CD. The surgical skill is often not avail-
able at district hospitals. Ideally, attempts 
should be made to train doctors at district 
hospital level to perform a subtotal hysterec-
tomy, but this may not be feasible; eligible 
cases would be infrequent, and there is often 
a high turnover of doctors. Alternatively, the 
doctor must perform conservative surgical 
measures and apply a uterine tourniquet 
before packing, closing and referring to a 
tertiary hospital.[20] 
Management algorithms for 
postpartum haemorrhage 
These have been revised in response to recent 
research, new technologies, review of influential 
PPH guidelines, new guidance on resuscitation 
in haemorrhagic shock and findings from the 
Saving Mothers reports (Figs 1 - 3).
Referral of patients 
with ongoing obstetric 
haemorrhage 
While the emphasis is on resuscitation and 
all possible interventions at the site where the 
delivery and PPH occurs, there will always be 
a need to refer patients, after PPH, to a higher 
level of care. This is because of the structure 
of the maternity system in SA, with different 
levels of care and surgical skill. In some patients 
the bleeding would have been stopped prior to 
transfer, which is required for management in 
an intensive care unit and blood replacement at 
a regional or tertiary hospital. In other patients, 
the bleeding would not have been definitively 
stopped and no more could be done at the 
referring institution. Unfortunately, many deaths 
occur in such patients during transit or shortly 
after arrival at the next level of care, which 
may be compounded by ambulance delays. To 
avoid this, the following is recommended: good 
communication with the receiving hospital – 
the senior obstetrician must advise the referring 
doctor of all possible temporising interventions 
before transfer; resuscitation and treatment 
to continue up to transfer, which should not 
be discontinued after transfer arrangements 
have been made; availability of paramedic-
assisted ambulances to be improved in most 
provinces so that resuscitation and treatment 
can be continued during transfer, and if possible 
a staff member must accompany the patient 
to assist with this. The non-pneumatic anti-
shock garment is a neoprene garment with 
compression panels on the lower limbs and 
abdomen, which treats shock by maintaining 
blood flow to essential organs during transit.[21] 
It is soon to be procured and piloted in SA and 
has great potential for improving the condition 
of shocked women during transfer so that they 
arrive alive and can be definitively managed at 
the next level of care.
Declaration. None.
Acknowledgements. National Committee for 
Confi den tial Enquiries into Maternal Deaths.
Author contributions. Sole author.
Funding. None.
Conflicts of interest. None.
1. National Department of Health. Saving Mothers 2014 - 2016. 
The Seventh Report of the National Committee for Confidential 
Enquiries into Maternal Deaths in South Africa. Pretoria: 
NDoH, 2017.
2. Fawcus S, Pattinson RB, Moodley J, et al. Maternal deaths from 
bleeding associated with caesarean delivery: A national emergency. 




  bleeding (revealed PPH)
• ↓BP + ↑HR + abdominal
  distension + pallor
  (concealed bleeding)
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  (not hypertensive/cardiac)
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• Haemostasis at initial caesarean section
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Resuscitate/early Rx
• 2nd IV line + uid
  resuscitation
• Maintain BP: uids/blood
• Oxytocin 20 IU in 1 L
  infusion
• Tranexamic acid 1 g IV
  slowly
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